Optics-based compressibility parameter for pharmaceutical tablets obtained with the aid of the terahertz refractive index by Chakraborty, M et al.
1 
 
Optics-based compressibility parameter for pharmaceutical tablets obtained with the 1 
aid of the terahertz refractive index  2 
Mousumi Chakraborty1*, Cathy Ridgway2, Prince Bawuah1, Daniel Markl3, Patrick A.C. 3 
Gane2,4, Jarkko Ketolainen5, J. Axel Zeitler3, Kai-Erik Peiponen1 4 
1Institute of Photonics, University of Eastern Finland, P.O. Box 111, FI-80101 Joensuu, 5 
Finland.  6 
2Omya International AG, CH-4665 Oftringen, Switzerland. 7 
3Department of Chemical Engineering and Biotechnology, University of Cambridge, 8 
Cambridge CB3 0AS, United Kingdom. 9 
4Aalto University, School of Chemical Engineering, Department of Bioproducts and 10 
Biosystems, FI-00076 Aalto, Helsinki, Finland. 11 
5School of Pharmacy, Promis Centre, University of Eastern Finland, P. O. Box 1617, FI-70211, 12 
Kuopio, Finland. 13 
Abstract 14 
The objective of this study is to propose a novel optical compressibility parameter for porous 15 
pharmaceutical tablets. This parameter is defined with the aid of the effective refractive index 16 
of a tablet that is obtained from non-destructive and contactless terahertz (THz) time-delay 17 
transmission measurement. The optical compressibility parameter of two training sets of 18 
pharmaceutical tablets with a priori known porosity and mass fraction of a drug was 19 
investigated. Both pharmaceutical sets were compressed with one of the most commonly used 20 
excipients, namely microcrystalline cellulose (MCC) and drug Indomethacin. The optical 21 
compressibility clearly correlates with the skeletal bulk modulus determined by mercury 22 
porosimetry and the recently proposed terahertz lumped structural parameter calculated from 23 
terahertz measurements. This lumped structural parameter can be used to analyse the pattern 24 
of arrangement of excipient and drug particles in porous pharmaceutical tablets. Therefore, we 25 
propose that the optical compressibility can serve as a quality parameter of a pharmaceutical 26 
tablet corresponding with the skeletal bulk modulus of the porous tablet, which is related to 27 
structural arrangement of the powder particles in the tablet.  28 
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Introduction  37 
For pharmaceutical applications tablets are the accepted and most widely used dosage form 38 
due to their being cost effective to manufacture, having relative ease of large scale of 39 
production, resulting product stability, related to the availability of reliable manufacture 40 
processes, and ability to provide correct reproducible dosage of drug from tablet to tablet and 41 
the convenience for patients [1, 2]. Critical quality attributes, such as disintegration time or 42 
amount of drug dissolved after a certain time, are linked to their physical, mechanical, 43 
chemical, biological and also optical properties. During formation of a tablet, the mixture of 44 
drug and excipient particles is compacted, usually directly or following a granulation step, into 45 
a stable porous solid. 46 
Historically, mechanical properties have played an important role in order to assess the 47 
functionality of a pharmaceutical tablet following the compaction step. Indentation, elasticity, 48 
tensile strength, brittle fracture index, bonding index, strain index, viscoelasticity, 49 
compressibility, compatibility, and tabletability are among the various mechanical properties 50 
of a tablet that have been explored in depth [3 - 8]. The mechanical properties of pharmaceutical 51 
tablets can be described by the relationship between the applied force during the compression 52 
and the resulting plastic deformation, and inter-particle bonding within the tablet [9]. These 53 
dictate the behaviour of pharmaceutical powder mixtures both during and after compaction. 54 
Stress and strain are the basic mechanical properties to describe the relationship between 55 
compressive pressure and the resulting deformation [8]. Compressibility (solid fraction as a 56 
function of compaction pressure) and compactibility (tensile strength in relation to solid 57 
fraction) [10] are terms commonly used to describe the densification and reduction in volume 58 
of a powder bed by the application of pressure alone, and both properties are considered to be 59 
the major parameters contributing to tabletability, defined as the dependence of tensile strength 60 
on compaction pressure [11]. In this study, we propose to establish an optical parameter that is 61 
related to the mechanical properties, such as the bulk modulus of pharmaceutical tablets. This 62 
topic of high importance in pharmaceutical sciences (see, for example, reference to strain [4 - 63 
8, 10] and compressibility [12 – 18]).  In this study, the emphasis is on the research of the 64 
development of non-contact sensing and data analysis methods to quantify structural and 65 
mechanical properties of pharmaceutical tablets using terahertz (THz) time-delay measurement 66 
techniques [19]. 67 
Recently, we have introduced a novel structural parameter (S), which describes the pattern of 68 
arrangement of different constituents in porous pharmaceutical tablets [20]. By pattern 69 
arrangement we mean the arrangement of drug and excipient constituting the skeletal-pore 70 
elements (solid phase) in series, parallel or a mix of both patterns. This structural parameter is 71 
assumed to play an important role both in the compressibility of a tablet, and in the description 72 
of the ingress and permeation of liquids in pharmaceutical tablets. In addition to developing 73 
the optical compressibility parameter, we consider in more detail the structural parameter S in 74 
respect to the explicit dependence of S on a range of various tablet properties, and analyse the 75 
correlation of the optical compressibility parameter with S.  76 
This study continues our work to retrieve physical parameters, which directly affect critical 77 
quality attributes of a tablet, from non-destructive and contactless terahertz measurements.  So 78 
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far, we have established correlation between the effective THz refractive index and porosity 79 
[21], surface roughness [21], lumped structural parameter [20], and Young’s modulus [8]. 80 
Here, we suggest a new optical compressibility parameter and compare it with the measured 81 
bulk modulus of tablets.  82 
Theory 83 
The data analysis in this study is based on the measurement of time delay (Δt) of a terahertz 84 
pulse. The time delay is caused by the more optically dense tablet compared to the undisturbed 85 
propagation of the pulse through nitrogen gas, which is typically used as a reference medium 86 
in laboratory terahertz measurements. Hence, we assume the validity of the following equation 87 
(𝑛eff − 1)𝐻 = 𝑐Δ𝑡                                                            (1) 88 
where neff is the effective refractive index of the tablet, H is the height of the round flat-faced 89 
tablet, corresponding in direction to the normal of incidence, and c is the velocity of light in 90 
vacuum. The refractive index of nitrogen is assumed to be equal to unity. 91 
In the derivation of the structural parameter S of a porous pharmaceutical tablet we exploited 92 
the concept of effective permittivity of the tablet and Wiener bounds that define the boundary 93 
range for the effective permittivity in the absence of scattering of the terahertz waves. Aspnes 94 
[22] provides a nice description of Wiener bounds for composite materials by considering two 95 
limiting cases, namely no screening and maximum screening of microstructures in the direction 96 
of the external electric field. This means that, for example, a needle –shaped particle orientated 97 
parallel to the external electric field (in our case direction of propagation of the THz pulse) 98 
would develop little screening, whereas a disc-shaped particle of the same volume would yield 99 
strong screening. The effective permittivity of a porous pharmaceutical tablet can be assumed 100 
to be constructed from parallel and series connections of the internal solid structures as follows 101 
[20]:  102 
𝜀eff =
1
1−S
εU
+
S
εL
                                                                  (2) 103 
where 𝜀U  and 𝜀L are the upper and lower Wiener bounds of the permittivity, respectively, and 104 
S is the structural parameter. S is a measure of that fractional part of the randomly distributed 105 
structures in a porous medium that can be lumped together in parallel and in series coordination, 106 
respectively. Since the true value of the effective permittivity of the tablet is always confined 107 
between the upper and lower values of the effective permittivity, the structural parameter S is 108 
a number that ranges from zero (all constituents in parallel) to one (all constituents in series). 109 
The definition of S holds equally for multiphase systems. In our study, we will only deal with 110 
a three-phase system, air and two solid phases, respectively. Eq. (2) was originally defined for 111 
effective heat conductivity [23] of porous media, such as coated paper products, but for the 112 
sake of analogy we have modified the concept for this analogous case, namely to represent the 113 
effective permittivity of porous media.  114 
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In the case of a three-phase system, such as air (or nitrogen gas), micro-crystalline cellulose 115 
(MCC) and the drug in this study, the equations for the upper and lower Wiener bounds of the 116 
effective refractive index are as follows: 117 
   𝑛U
2 = 𝑓air + 𝑓MCC𝑛MCC
2 + 𝑓drug𝑛drug
2                                                       (3)       118 
 119 
and                                                                   120 
    
1
𝑛L
2 = 𝑓air + 
𝑓MCC
𝑛MCC
2 +
𝑓drug
𝑛drug
2                                                                       (4) 121 
where fair, fMCC and fdrug are the volume fractions of air (i.e. the pores constituting the tablet 122 
porosity), MCC and drug, respectively. The symbols nMCC and ndrug denote the intrinsic 123 
refractive indices of MCC and drug. If we apply the well-known relation from optics for the 124 
real relative permittivity and the refractive index of a non-absorbing insulating medium, 125 
namely, 𝑛 = √𝜀, we get from Eqs. (2)-(4) the expression 126 
𝑆 =
1
𝑛U
2 −𝑛L
2 [
𝑛U
2 𝑛𝐿
2
𝑛eff
2 − 𝑛L
2]                                                                    (5) 127 
In the pharmaceutical industry, the compressibility of pharmaceutical tablet formulations is an 128 
important factor which determines the required applied force on the composition of powder 129 
mixture to turn it into a structurally stable porous tablet. It greatly affects a range of tablet 130 
properties such as disintegration, dissolution, structural integrity, bioavailability and 131 
absorption as well as the mechanical properties, such as hardness and friability. The 132 
compressibility is defined as a mechanical property, which describes the relationship between 133 
the resulting compact density or strength (hardness / friability) and the compaction pressure 134 
[24].  135 
We propose an “optical compressibility” parameter to estimate the mechanical compressibility 136 
of an excipient or complex formulation based on a simple analysis of the transmitted terahertz 137 
pulse. This “optical compressibility” is defined by using Eq. (1) as an optical state equation in 138 
analogy to the equation of state of a medium in thermodynamics. For the sake of clarity, we 139 
first consider the simple thermodynamic equation of state of an ideal gas, which is defined with 140 
the aid of the pressure (p), volume (V), absolute temperature (T), the number of gas molecules 141 
(υ) and the gas constant (R) as pV = υRT. The optical state equation, namely Eq. (1), resembles 142 
the mathematical form of the thermodynamic state equation of an ideal gas, but obviously has 143 
different variables. The compressibility β, of an ideal gas is defined using the concept of a 144 
partial derivative as follows: 145 
𝛽 = −
1
𝑉
(
𝜕𝑉
𝜕𝑝
)
𝑇
=
1
𝑝
                                                                (6) 146 
The unit of this compressibility is Pa-1. A definition similar to Eq. (6) can be exploited also for 147 
the compressibility of liquids and solids in the field of thermodynamics, but usually the state 148 
equation is more complicated than that of an ideal gas. The interpretation of Eq. (6) states that 149 
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the higher the pressure, the lower is the value of the compressibility. In an analogous manner 150 
to Eq. (6), we define with the aid of Eq. (1) the optical compressibility parameter as 151 
𝛽𝑇𝐻𝑧 = −
1
𝐻
(
𝜕𝐻
𝜕𝑛eff
)
Δ𝑡
=
1
𝑛eff−1
                                                       (7) 152 
The dimensionless optical compressibility defined in this way shows inverse dependence of 153 
the compressibility on the effective refractive index, which in turn is linearly correlated to the 154 
density/porosity of the tablet. The interpretation of Eq. (7) is that the denser the medium (i.e. 155 
higher compaction pressure) the higher the effective refractive index, since the density of a 156 
medium is correlating with the refractive index of the medium, and, hence, the lower the optical 157 
compressibility parameter. 158 
Next, we wish to have a more detailed picture regarding the behaviour of the optical 159 
compressibility parameter defined in Eq. (7). For this purpose, we consider an estimate for the 160 
explicit dependence of the optical compressibility on porosity, intrinsic refractive index of the 161 
excipient and the drug, and also drug mass fraction. An expression for the linear two-variable 162 
(fair, x) approximate effective refractive index of the tablet training sets of this study was given 163 
in [25] as follows: 164 
𝑛eff = 𝑛MCC − (𝑛MCC − 1)𝑓air − (𝑛MCC − 𝑛drug)𝑥   ,  (8) 165 
  166 
where x is the dimensionless mass fraction (different from fdrug) of the drug. By substituting 167 
Eq. (8) into Eq. (7), the optical compressibility can be re-expressed as, 168 
𝛽THz =
1
(𝑛MCC−1)(1−𝑓air)−(𝑛MCC−𝑛drug)𝑥 
    (9)                                                                                       169 
Since nMCC and ndrug are constants, it is evident from Eq. (9) that 𝛽THz is inversely dependent 170 
(hyperbolic dependence) on the porosity fair or mass fraction x only when one of them is 171 
constant. In a general case, both porosity and the dimensionless mass fraction are considered 172 
to vary. 173 
The optical compressibility βTHz depends on S via Eq. (5). If we compare Eqs. (6) and (7), the 174 
message is pretty much similar. The thermodynamic compressibility β becomes less as the 175 
pressure increases. In the case of increasing compression pressure in the tableting process the 176 
porosity of the tablet is decreasing and the effective refractive index is increasing, thus resulting 177 
in the decrease of βTHz. The optical compressibility parameter βTHz and its connection to the S 178 
structure parameter was studied for the training set of pharmaceutical tablets, and the results 179 
obtained will be shown below.  180 
Materials and methods 181 
Two sets of round flat-faced pharmaceutical tablets were compressed from the defined 182 
mixtures of pharmaceutical excipient MCC (Avicel PH101, FMC BioPolymer, Philadelphia, 183 
USA) and drug Indomethacin (Hangzhou Dayangchem Co. Ltd., Hangzhou, China). The 184 
widely used MCC is a typical hydrophilic excipient [21], the nominal particle size and true 185 
density of the particulate Avicel PH101 are 50 μm and 1.55 g cm-3, respectively. The true 186 
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density of the crystalline gamma polymorph of Indomethacin used in this study is 1.37 g cm-3. 187 
Two training sets of flat-faced tablets of constant diameter 13 mm were compacted using a 188 
compaction simulator (PuuMan, Kuopio, Finland). More details on the sample preparation of 189 
the tablets were described previously [26-28]. In Tables 1 and 2, various properties of the 190 
training tablet sets are presented. In tablet Set 1, porosity and drug mass fractions were kept 191 
constant at ca. 36 % and 10 wt%, respectively, whereas both were varied for the case of the 192 
tablet Set 2. For both tablet sets, five tablets were compressed for each sample number and the 193 
given values in Tables 1 and 2 are the average values of 5 tablets belonging to a given tablet 194 
number. For each sample, statistical errors in the calculations made for the nominal porosities 195 
are as follows: diameter ± 0.008 mm, height ± 0.005 mm (standard deviation of the sample 196 
mean), weight ± 0.01 mg (readability and sensitivity of the scale), effective refractive index 197 
±0.002 (by assuming a temporal resolution of 0.02 ps) and porosity ± 0.2 % (calculated using 198 
the error propagation law).  199 
Here we report on two case studies related to the lumped structural S parameter and the optical 200 
compressibility as follows: Case 1; fixed porosity and fixed drug mass fraction but variable 201 
height, and Case 2; varied porosity, drug mass fraction and height. To calculate the S parameter, 202 
presented in Tables 1 and 2, we have to utilise Eqs. (1) - (5). In order to solve Eqs. (3) and (4), 203 
we have to know the zero porosity refractive indices of nMCC and ndrug, namely, nMCC =1.86 and 204 
ndrug =1.73. The latter value of zero porosity estimate of the refractive index of ndrug is a better 205 
estimate than the one given in [25]. The zero porosity estimates of the refractive index of MCC 206 
and drug were obtained by the linear extrapolation technique method as used in [20, 25, 28].  207 
The density of the samples was calculated from the average dimensions and the average 208 
measured weight of the tablet. The tablet porosity was calculated by forming a ratio between 209 
the tablet density and the true density of MCC and Indomethacin, and the S parameter was 210 
calculated by using the equations given in the theory section. In Table 1, we have numbered 211 
the samples according to the order of the increase of the tablet height, not the order of increase 212 
of the effective refractive index. 213 
Table 1:   Data of tablet Set 1. The mean values of the diameter d, height H, weight W, porosity 214 
fair, effective refractive index neff, drug mass fraction wt% (x) and calculated S parameter for 215 
four samples are shown. Since the porosity for all of the tablet samples is known, it is possible 216 
to calculate the volume fractions of MCC and drug, as was discussed in [20].  217 
Sample 
number 
(Set 1) 
d 
(mm) 
H 
(mm) 
W 
(mg) 
fair 
(%) 
neff 
 
x 
(wt%) 
S 
1 13.097 2.742 361.47 36 1.529 10 0.220 
2 13.078 3.333 438.73 36 1.533 10 0.206 
3 13.066 3.626 476.45 36 1.537 10 0.194 
4 13.062 3.927 514.70 36 1.535 10 0.198 
 218 
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Table 2: Data of tablet Set 2. The values of the diameter d, height H, weight W, porosity fair, 219 
effective refractive index neff, drug mass fraction wt% (x) and calculated S parameter for five 220 
pharmaceutical tablets are shown.  221 
Sample 
number 
(Set 2) 
d  
(mm) 
H  
(mm) 
W  
(mg) 
fair  
(%) 
neff x 
(wt%) 
S 
1 13.076 3.955 404.02 50 1.405 11.00 0.271 
2 13.075 3.642 403.64 46 1.441 10.50 0.253 
3 13.094 3.273 405.67 40 1.498 10.00 0.219 
4 13.093 2.971 404.23 34 1.551 9.50 0.201 
5 13.081 2.734 406.20 28 1.602 9.00 0.194 
 222 
Skeletal bulk modulus determination 223 
Mercury intrusion measurements were conducted using an Autopore V mercury porosimeter 224 
(Micromeritics Instrument Corporation, Norcross, GA, U.S.A.). The maximum applied 225 
pressure of mercury is 414 MPa, equivalent to a Laplace throat diameter of 4 nm. The 226 
equilibration time at each of the increasing applied pressures of mercury is set to 20 s. The 227 
tablets are measured as supplied.  228 
By observing the behaviour under intrusion and extrusion at the highest pressures it is possible 229 
to ascertain whether the sample displays the typical pore retention hysteresis or whether 230 
mercury is extruded initially at equal volume to that during intrusion as a function of pressure. 231 
If the latter occurs, then it is possible to conclude that the skeletal material is being elastically 232 
compressed, and the gradient of the elastic response to pressure provides a measure of the 233 
elastic bulk modulus of the skeletal material, i.e. the material bulk modulus of the pore wall 234 
when compressed equally from all directions. If the extrusion, however, exceeds the intrusion 235 
then the skeletal material is partially undergoing strong plastic deformation. The plastic 236 
deformation, however, is generally impossible to quantify as it is convoluted with the usual 237 
mercury retention hysteresis due to necking and filament snapping, and ink bottle behaviour. 238 
Thus, correcting for the elastic behaviour in the data can be included in the overall data 239 
correction during the mercury intrusion comprising the more commonly known effects of 240 
compression of mercury and expansion of the penetrometer [1]. This is performed conveniently 241 
using the software Pore-Comp (a software program developed by and obtainable from the 242 
Environmental and Fluids Modelling Group, University of Plymouth, U.K.), in which the 243 
following equation is applied: 244 













 
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
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

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
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     (10) 245 
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where Vint is the volume of intrusion into the sample, Vobs the intruded mercury volume reading, 246 
Vblank the change in the blank run volume reading, V1bulk  the sample bulk volume at 247 
atmospheric pressure, P the applied pressure, 1 the porosity at atmospheric pressure, P1 the 248 
atmospheric pressure and Mss the bulk modulus of the solid sample [29]. 249 
Results and discussion  250 
The values for the optical compressibility parameter, βTHz, for the case of Set 1 are shown in 251 
Fig. 1 as a function of S. The porosity and drug mass fraction were kept constant and only the 252 
height of the tablets was increased in this Set 1, which causes an increase in the volume of the 253 
tablet. The increase of the volume can be a probable reason for differences in arrangement of 254 
the particles in the direction of the THz pulse propagation, and hence different values of the 255 
lumped structural parameter S. From Table 1 it is evident that the refractive index of the tablets 256 
vary only slightly, whereas much stronger variations can be observed for their structural 257 
parameter S, sensitive to the series-parallel arrangement of constituents in the tablets.  258 
Assuming that all the tablets of Set 1 have the same porosity and drug wt%, the conclusion can 259 
be drawn that a different share of series and parallel arrangement of the skeleton structure of 260 
the tablets contributes to slightly different values of the effective refractive index, and that this 261 
is manifested by a rather big change in the value of S. Therefore, S has a descriptor role 262 
regarding also the compressibility of a tablet. Actually, the different heights of the nominally 263 
similar tablets of Set 1 generate essentially different shares of series and parallel structures and, 264 
hence, different values of S. In other words, the packing of drug and MCC is different according 265 
to the different tablet heights, and thus, compression. 266 
For the samples in the case of Set 2 we repeated the same analysis procedure as above. Note 267 
that in this case the samples follow a different numbering rule, to the extent that when the tablet 268 
height is decreasing (the volume of the tablet becomes smaller) the effective refractive index 269 
is increasing, as shown in Table 2. In Fig. 2 we plot the structural parameter as a function of 270 
the porosity for Set 2. Here, dependence of the structural parameter S on the porosity suggests 271 
a nonlinear relationship, which can be mathematically deduced from Eqs. (3) - (5). The range 272 
of variation of S in this case of Set 2 is ca. 0.194 - 0.271, which is much wider than for the case 273 
of Set 1, ca. 0.198 - 0.220. In the case of Set 2, porosity and drug are both subject to being 274 
varied. A wider range of porosity change suggests also a wider range of the magnitude of the 275 
structural parameter S. 276 
The optical compressibility parameter βTHz as a function of S for tablet Set 2 is shown in Fig. 277 
3. The optical compressibility βTHz is increasing with increasing S. The optical compressibility 278 
range of Set 2 is ca 1.66 - 2.47, which is wider than that of Set 1 ca. 1.86 -1.89. Since both the 279 
porosity and the drug mass fraction have been changing in the situation of Set 2, it is necessarily 280 
more complex than in the case of Set 1.  281 
Besides the correlation of βTHz with the parameter S we also studied the explicit dependence of 282 
βTHz on fair and x (shown in Figs. 4 and 5). Fig. 4 suggests a nonlinear, hyperbolic dependence 283 
of βTHz on fair. This is consistent with the estimate given in Eq. (9), namely a hyperbolic 284 
dependence of βTHz on fair. The data of Fig. 5 show apparently a weaker nonlinearity in respect 285 
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to the dependence on x. However, if the mass fraction x would have a wider scale of variation, 286 
hyperbolic dependence of βTHz on x would also be expected.  287 
Fig 6 shows the calculated optical compressibility parameter as a function of the measured 288 
mechanical parameter, namely skeletal bulk modulus. It is obvious that there is a correlation 289 
between the optical compressibility and the skeletal bulk modulus. The change of the optical 290 
compressibility is relatively strong as a function of the skeletal bulk modulus if we compare 291 
the samples 3-5 of this set 2, which present low porosity tablets with the lowest drug loadings 292 
amongst the present samples. 293 
The skeletal bulk modulus of the sample number 1 of Set 2 (Table 2) has the highest value and 294 
so the least compressible skeletal solid material of the five samples. This sample has the highest 295 
drug loading, and so the ratio of drug to compressible excipient is the highest. Sample number 296 
5 of Set 2 (Table 2) in turn has the most compressible skeletal material corresponding with the 297 
lowest drug loading. The drug, therefore, has a high material bulk modulus, and in ratio with 298 
the more compressible excipient determines the observed compressibility of the tablet 299 
structure. 300 
In this study, we have introduced the concept of an optical compressibility parameter at the 301 
example of a specific formulation of MCC and drug. Our experiments were limited to this 302 
system due to the experimental constraint of having to prepare, measure and analyse the 303 
samples between a number of sites. However, the measurement principle is universally 304 
applicable and we are planning to continue similar investigations of the optical compressibility 305 
for a range of different excipients, such as functionalised calcium carbonate (FCC), which we 306 
have recently studied with the aid of terahertz techniques [30]. Before developing the concept 307 
further, it will be important to better understand the relationship between the mechanical 308 
properties of the powder compact, liquid mass transport in the tablet matrix and disintegration, 309 
which we are pursuing with the samples introduced in this paper by means of in situ terahertz 310 
imaging during disintegration as outlined in [31]. 311 
 312 
Conclusions 313 
Compressibility of a pharmaceutical tablet is an important tablet property. The problem of 314 
measuring compressibility of a tablet is challenging because one needs to detect the change in 315 
volume of a tablet as a function of the compression pressure. This means, typically, that special 316 
measurement arrangements have to be realised under well-controlled laboratory conditions. 317 
Our idea outlined in this paper is to retrieve information on compressibility and, hence, 318 
mechanical properties of a tablet using a non-destructive method based on the THz pulse delay 319 
detection. In this article, we have introduced the concept of optical compressibility of 320 
pharmaceutical tablets.  321 
The optical compressibility was studied for two training tablet sets. A theoretical model that 322 
gives explicit dependence of the optical compressibility of porosity and drug mass fraction was 323 
given. The tablets of two differently compressed sets consisted of one excipient, MCC, and one 324 
drug, Indomethacin. For the purpose of describing their compressibility, we derive the concept 325 
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of optical compressibility based on the effective refractive index of a tablet. The difference 326 
between the conventional and optical compressibility is that in the latter case there is, in 327 
principle, no longer a need to evaluate physical compressibility by detection of any pressure-328 
induced volume change of the tablet. However, there is a valuable subtlety arising from the 329 
change in packing structure as a function of unidirectional compression. This is seen in a 330 
change of the parallel to series coordination of the skeletal material as monitored by the lumped 331 
parameter structure factor S. Thus, it is possible to derive a compressibility using the optical 332 
approach, and that this optical compressibility is unique to the excipient-drug formulation ratio 333 
in that the compression of the tablet leads to a change in effective refractive index together 334 
with a unique packing change. Thus, the combination of neff and S as a function of compressive 335 
force provides a quality control tool for both tablet compression and formulation consistency. 336 
The transmitted terahertz signal, therefore, gives volumetric and structural information on the 337 
tablet as it stands without using any external disturbance. In other words, the optical 338 
compressibility is an intrinsic property of each tablet and its formulation.  339 
Relatively regular behaviour of the optical compressibility as a function of the structural 340 
parameter, S, porosity fair, and drug mass fraction x, was obtained for both tablet Sets 1 and 2. 341 
Using the data of skeletal bulk modulus of Set 2 we found a correlation between the optical 342 
compressibility and bulk modulus. The bulk modulus relates only to the direct compressibility 343 
of the material itself making up the skeleton but not that of the skeleton structure.    344 
The study of the structural parameter, as well as the optical compressibility provides a more 345 
comprehensive picture of the properties of a pharmaceutical tablet, and in principle can be used 346 
to understand better the mechanical properties such as strain, Young’s modulus, Poisson’s ratio 347 
etc. of a tablet. 348 
Finally, we wish to remark that both the lumped structural parameter as well as the optical 349 
compressibility are suggested to be proportional to the surface roughness of a tablet [21]. It 350 
was demonstrated previously that the effective refractive index of tablets is proportional to the 351 
measured average surface roughness. This observation may open new ways to predict various 352 
properties of tablets by terahertz measurements in reflection setting, i.e. reflection of the THz 353 
pulse. Such a concept would be particularly beneficial when the drug or excipient strongly 354 
absorbs THz radiation, rendering transmission measurements unfeasible. 355 
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